Investor Relations

We are a clinical-stage biopharmaceutical company focused on metabolic and endocrine disorders. We improve compliance, absorption, and more with our proprietary drug delivery technology.

Stock Information

NASDAQLPCN
$0.37
NASDAQLPCN
Open
$0.40
Change
-$0.02 (-6.07%)
Day's Range
$0.35 - $0.40
52-Week Range
$0.36 - $3.46
Volume
921.7K
Market Cap
$13.3M